5 policy changes reshaping blood specimen logistics in 2026

أضاف وظيفة جديدة Enerji Çalışmaları

2026-02-02 07:03:31 -

As 2026 unfolds, international regulatory bodies are introducing rigorous cold-chain transparency requirements to ensure the viability of specimens used in advanced regenerative medicine. Recent directives from the European Medicines Agency and partner organizations in Asia emphasize the need for real-time temperature monitoring from the point of care to the processing facility. This regulatory...

0 التعليقات 0 المشاركات 397 مشاهدة 0 معاينة